Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.

Among human RNA viruses, hepatitis C virus (HCV) is unusual in that it causes persistent infection in the majority of infected people. To establish persistence, HCV evades host innate and adaptive immune responses by multiple mechanisms. Recent studies identified virus genome-derived small RNAs (vsR...

Full description

Bibliographic Details
Main Authors: Nirjal Bhattarai, James H McLinden, Jinhua Xiang, M Meleah Mathahs, Warren N Schmidt, Thomas M Kaufman, Jack T Stapleton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-02-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1006232
_version_ 1818666971140456448
author Nirjal Bhattarai
James H McLinden
Jinhua Xiang
M Meleah Mathahs
Warren N Schmidt
Thomas M Kaufman
Jack T Stapleton
author_facet Nirjal Bhattarai
James H McLinden
Jinhua Xiang
M Meleah Mathahs
Warren N Schmidt
Thomas M Kaufman
Jack T Stapleton
author_sort Nirjal Bhattarai
collection DOAJ
description Among human RNA viruses, hepatitis C virus (HCV) is unusual in that it causes persistent infection in the majority of infected people. To establish persistence, HCV evades host innate and adaptive immune responses by multiple mechanisms. Recent studies identified virus genome-derived small RNAs (vsRNAs) in HCV-infected cells; however, their biological significance during human HCV infection is unknown. One such vsRNA arising from the hepatitis C virus (HCV) E2 coding region impairs T cell receptor (TCR) signaling by reducing expression of a Src-kinase regulatory phosphatase (PTPRE) in vitro. Since TCR signaling is a critical first step in T cell activation, differentiation, and effector function, its inhibition may contribute towards HCV persistence in vivo. The effect of HCV infection on PTPRE expression in vivo has not been examined. Here, we found that PTPRE levels were significantly reduced in liver tissue and peripheral blood mononuclear cells (PBMCs) obtained from HCV-infected humans compared to uninfected controls. Loss of PTPRE expression impaired antigen-specific TCR signaling, and curative HCV therapy restored PTPRE expression in PBMCs; restoring antigen-specific TCR signaling defects. The extent of PTPRE expression correlated with the amount of sequence complementarity between the HCV E2 vsRNA and the PTPRE 3' UTR target sites. Transfection of a hepatocyte cell line with full-length HCV RNA or with synthetic HCV vsRNA duplexes inhibited PTPRE expression, recapitulating the in vivo observation. Together, these data demonstrate that HCV infection reduces PTPRE expression in the liver and PBMCs of infected humans, and suggest that the HCV E2 vsRNA is a novel viral factor that may contribute towards viral persistence.
first_indexed 2024-12-17T06:13:00Z
format Article
id doaj.art-79fc8ec3de004f78ad5c3eef85bbee22
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-17T06:13:00Z
publishDate 2017-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-79fc8ec3de004f78ad5c3eef85bbee222022-12-21T22:00:35ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742017-02-01132e100623210.1371/journal.ppat.1006232Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.Nirjal BhattaraiJames H McLindenJinhua XiangM Meleah MathahsWarren N SchmidtThomas M KaufmanJack T StapletonAmong human RNA viruses, hepatitis C virus (HCV) is unusual in that it causes persistent infection in the majority of infected people. To establish persistence, HCV evades host innate and adaptive immune responses by multiple mechanisms. Recent studies identified virus genome-derived small RNAs (vsRNAs) in HCV-infected cells; however, their biological significance during human HCV infection is unknown. One such vsRNA arising from the hepatitis C virus (HCV) E2 coding region impairs T cell receptor (TCR) signaling by reducing expression of a Src-kinase regulatory phosphatase (PTPRE) in vitro. Since TCR signaling is a critical first step in T cell activation, differentiation, and effector function, its inhibition may contribute towards HCV persistence in vivo. The effect of HCV infection on PTPRE expression in vivo has not been examined. Here, we found that PTPRE levels were significantly reduced in liver tissue and peripheral blood mononuclear cells (PBMCs) obtained from HCV-infected humans compared to uninfected controls. Loss of PTPRE expression impaired antigen-specific TCR signaling, and curative HCV therapy restored PTPRE expression in PBMCs; restoring antigen-specific TCR signaling defects. The extent of PTPRE expression correlated with the amount of sequence complementarity between the HCV E2 vsRNA and the PTPRE 3' UTR target sites. Transfection of a hepatocyte cell line with full-length HCV RNA or with synthetic HCV vsRNA duplexes inhibited PTPRE expression, recapitulating the in vivo observation. Together, these data demonstrate that HCV infection reduces PTPRE expression in the liver and PBMCs of infected humans, and suggest that the HCV E2 vsRNA is a novel viral factor that may contribute towards viral persistence.https://doi.org/10.1371/journal.ppat.1006232
spellingShingle Nirjal Bhattarai
James H McLinden
Jinhua Xiang
M Meleah Mathahs
Warren N Schmidt
Thomas M Kaufman
Jack T Stapleton
Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
PLoS Pathogens
title Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
title_full Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
title_fullStr Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
title_full_unstemmed Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
title_short Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
title_sort hepatitis c virus infection inhibits a src kinase regulatory phosphatase and reduces t cell activation in vivo
url https://doi.org/10.1371/journal.ppat.1006232
work_keys_str_mv AT nirjalbhattarai hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo
AT jameshmclinden hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo
AT jinhuaxiang hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo
AT mmeleahmathahs hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo
AT warrennschmidt hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo
AT thomasmkaufman hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo
AT jacktstapleton hepatitiscvirusinfectioninhibitsasrckinaseregulatoryphosphataseandreducestcellactivationinvivo